Caplin Point Laboratories informs about outcome of board meeting

27 May 2023 Evaluate
Caplin Point Laboratories has informed that the Board of Directors, at its meeting held today, has approved the following: Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023; Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend; Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). It also enclosed a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4); Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2 each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1882.90 -35.25 (-1.84%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×